HDEF - ETF AI Analysis

Top Page

Xtrackers MSCI EAFE High Dividend Yield Equity ETF (HDEF)

Rating:68Neutral

Price Target:―

HDEF, the Xtrackers MSCI EAFE High Dividend Yield Equity ETF, has a solid overall rating driven by high-quality, dividend-focused holdings like Novartis and TotalEnergies, which combine strong financial performance, supportive valuations, and positive earnings sentiment. Other large positions such as Roche, Nestlé, and Zurich Insurance also add stability, though some names like Allianz and Unilever face bearish technical trends or valuation concerns that slightly weigh on the fund. The main risk factor is its concentration in a relatively small group of large international companies, where technical weakness or overvaluation in a few key holdings could impact overall returns.

Positive Factors

Strong Leading Holdings

Several of the largest positions, such as Roche and Novartis, have shown solid gains this year, helping support the fund’s overall results.

Low Expense Ratio

The fund charges a relatively low fee, which means more of the dividend income and price gains can stay in investors’ pockets over time.

Broad International Diversification

Exposure across many developed markets outside the U.S., including Switzerland, the UK, France, Germany, and Japan, helps spread country-specific risk.

Negative Factors

Mixed Recent Performance

The ETF’s year-to-date return has been slightly negative, showing that it has struggled to gain steady upward momentum so far this year.

Concentration in a Few Countries

A large share of assets is concentrated in Switzerland and the UK, which increases the impact that economic or political issues in those markets can have on the fund.

Heavy Tilt to Financials and Defensives

Significant weight in financial, consumer defensive, and utility stocks may cause the fund to lag when more growth-oriented or technology sectors lead the market.

HDEF vs. SPDR S&P 500 ETF (SPY)

AUM2.36B

RegionDeveloped Markets

Expense Ratio0.09%

Beta0.42

IssuerXtrackers

Inception DateAug 12, 2015

Dividend Yield3.58%

Asset ClassEquity

Index TrackedMSCI EAFE High Dividend Yield

Share Statistics

EPS (TTM)N/A

Shares OutstandingN/A

10 Day Avg. Volume202,522

30 Day Avg. Volume155,993

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

34.41

Price Target Upside― Downside

Rating ConsensusModerate Buy

Number of Analyst Covering115

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

HDEF Summary

HDEF is an ETF that follows the MSCI EAFE High Dividend Yield Index, focusing on companies in developed markets outside the U.S. and Canada, such as Europe and Japan. It mainly holds large, established businesses that pay relatively high dividends, including well-known names like Nestlé and Shell. Investors might consider HDEF if they want international diversification and a potential income stream from dividends rather than just growth. A key risk is that the fund is concentrated in foreign and dividend-focused stocks, so its value and income can go up and down with global markets and interest-rate changes.

How much will it cost me?The expense ratio for HDEF is 0.09%, which means you’ll pay $0.90 per year for every $1,000 invested. This is lower than average because HDEF is passively managed, tracking an index rather than relying on active stock selection.

What would affect this ETF?HDEF could benefit from stable dividend payouts and growth in developed markets outside North America, especially if sectors like financials and healthcare, which have significant weight in the ETF, perform well. However, challenges such as rising interest rates, economic slowdowns in Europe or Asia, or regulatory changes affecting top holdings like Novartis or Shell could negatively impact returns. Diversification across sectors and regions provides some resilience, but global economic conditions remain a key factor to watch.

HDEF Top 10 Holdings

HDEF is leaning heavily on European health care giants Roche and Novartis, which have been quietly rising and doing much of the heavy lifting for the fund. Energy name TotalEnergies and tobacco player British American Tobacco are also adding some spark, with steadier to improving trends. On the flip side, consumer staples icons Nestlé and Unilever look tired, while Zurich Insurance has been dragging performance. Overall, the ETF is concentrated in financials, consumer defensives, and health care, with a distinctly developed-markets ex-U.S. and Canada flavor, led by Europe.

Name	Company Name	Weight %	Market Value	Market Cap	Yearly Gain	Overall Rating
ROG	Roche Holding AG	5.78%	$136.48M	CHF285.32B	41.42%	73 Outperform
NOVN	Novartis AG	5.54%	$130.69M	CHF234.28B	25.89%	80 Outperform
SHEL	Shell (UK)	4.75%	$112.01M	£164.82B	9.90%	73 Outperform
NESN	Nestlé SA	4.51%	$106.52M	CHF197.91B	9.29%	71 Outperform
ALV	Allianz	4.12%	$97.16M	€138.90B	11.82%	67 Neutral
ULVR	Unilever	3.87%	$91.38M	£116.01B	5.48%	72 Outperform
IBE	Iberdrola	3.74%	$88.20M	€133.59B	47.48%	67 Neutral
TTE	TotalEnergies SE	3.71%	$87.48M	€138.53B	4.82%	78 Outperform
BATS	British American Tobacco	3.23%	$76.28M	£95.99B	43.00%	71 Outperform
SAN	Sanofi	2.65%	$62.57M	€100.00B	-12.00%	75 Outperform

HDEF Technical Analysis

Technical Analysis Sentiment

Positive

Last Price―

Price Trends

50DMA

31.27

Positive

100DMA

30.41

Positive

200DMA

29.43

Positive

Market Momentum

MACD

0.63

Negative

RSI

77.21

Negative

STOCH

96.67

Negative

Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For HDEF, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 32.06, equal to the 50-day MA of 31.27, and equal to the 200-day MA of 29.43, indicating a bullish trend. The MACD of 0.63 indicates Negative momentum. The RSI at 77.21 is Negative, neither overbought nor oversold. The STOCH value of 96.67 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HDEF.

HDEF Peer Comparison

Comparison Results

Name	Price	Price Target	AUM	Expense Ratio	Overall Rating
HDEF	―	―	$2.36B	0.09%	―
IDV	―	―	$7.78B	0.50%	―
DIVI	―	―	$2.32B	0.09%	―
DTH	―	―	$648.74M	0.58%	―
FIDI	―	―	$270.13M	0.19%	―
EFAS	―	―	$43.15M	0.56%	―

Performance Comparison

HDEF

Xtrackers MSCI EAFE High Dividend Yield Equity ETF

33.55

8.47

33.77%

IDV

iShares International Select Dividend ETF

―

DIVI

Franklin LibertyQ International Equity Hedged ETF

―

DTH

WisdomTree International High Dividend Fund

―

FIDI

Fidelity International High Dividend ETF

―

EFAS

Global X MSCI SuperDividend EAFE ETF

―

Glossary

BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―

Table of Contents